Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
“These results suggest strong potential for clinical use of the assay in ctDNA monitoring of solid tumor cancers.”Credit: 2024 Northcott et al. “These results suggest...